PATTY BENSON: Open Payments
NPI 1639897317 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 52 payments from 29 companies in 2025. Trend: 2023 $1,224 · 2024 $1,701 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $160 |
| Novartis Pharmaceuticals Corporation | 6 | $147 |
| Janssen Biotech, Inc. | 4 | $90 |
| BeOne Medicines USA, Inc. | 3 | $57 |
| Celgene Corporation | 3 | $55 |
| ABBVIE INC. | 3 | $51 |
| Stemline Therapeutics Inc. | 2 | $37 |
| ARRAY BIOPHARMA INC | 2 | $33 |
| BeiGene USA, Inc. | 1 | $29 |
| PharmaEssentia USA Corporation | 1 | $28 |
Products named: LIBTAYO, REBLOZYL, BRUKINSA, KISQALI, EPKINLY, ERLEADA, Fabhalta, LYNOZYFIC.
Industry payments across AL — which companies pay providers there.
